Contact Information: Contact Info: Richard Oh 631-757-1500 631-757-2100 (fax) www.taglich.com
Taglich Brothers Initiates Coverage on Pressure BioSciences, Inc.
| Source: PRESSURE BIOSCIENCES, INC.
NEW YORK, NY -- (MARKET WIRE) -- January 9, 2007 -- Taglich Brothers, Inc. announces
it initiated coverage of Pressure BioSciences, Inc. (NASDAQ : PBIO ).
Pressure BioSciences (NASDAQ : PBIO ), headquartered in
West Bridgewater, MA, has developed Pressure Cycling Technology, which uses
cycles of hydrostatic pressure to control biomolecular interactions. This
technology can be applied in genomic and proteomic sample preparation,
pathogen inactivation, control of enzymes, immunodiagnostics and protein
purification. The company markets its Barocycler™ system and PULSE tube
sample containers to research laboratories in academia, government and
industry.
The complete 19-page report is available at www.taglichbrothers.com.
Taglich Brothers, Inc. is a
full-service broker dealer focused exclusively on microcap companies. The
Company defines the microcap segment of the equity market as companies with
less than $250 million in market capitalization. Taglich Brothers currently
offers institutional and retail brokerage services, investment banking and
comprehensive research coverage to the investment community.
* The information and statistical data contained herein have been obtained
from sources, which we believe to be reliable but in no way are warranted
by us as to accuracy or completeness. We do not undertake to advise you as
to changes in figures or our views. This is not a solicitation of any order
to buy or sell. Taglich Brothers, Inc. is fully disclosed with its clearing
firm, Pershing, LLC, is not a market maker and does not sell to or buy from
customers on a principal basis. The above statement is the opinion of
Taglich Brothers, Inc. and is not a guarantee that the target price for the
stock will be met or that predicted business results for the company will
occur. There may be instances when fundamental, technical and quantitative
opinions contained in the above-mentioned report are not in concert. We,
our affiliates, any officer, director or stockholder or any member of their
families may from time to time purchase or sell any of the above-mentioned
or related securities. Analysts and members of the Research Department are
prohibited from buying or selling securities issued by the companies that
Taglich Brothers, Inc. has a research relationship with, except if
ownership of such securities was prior to the start of such relationship,
then an Analyst or member of the Research Department may sell such
securities after obtaining expressed written permission from the Director
of Research. As of the date of this report, we, our affiliates, any
officer, director or stockholder, or any member of their families do not
have a position in the stock Pressure BioSciences, Inc. All research issued
by Taglich Brothers, Inc. is based on public information. The company paid
a monetary engagement fee of $19,500 (USD) for the first year of creation
and dissemination of research reports and will pay a monthly monetary fee
of $1,750 (USD) to Taglich Brothers, Inc. for these services after the
first year.